On July 30th, we welcomed members of Eli Lilly and Company[1], the State of Ohio, our partners at REDI Cincinnati[2], JobsOhio[3], and the Ohio Life Sciences Association[4], as well as a number of special guests, to our facility in Greater Cincinnati, Ohio. During the celebration, we announced our expanded strategic partnership with Eli Lilly and Company, backed by a $750 million investment to increase U.S. production of Lillys KwikPen® injectable device for diabetes and obesity medicines. Read the full press release here: https://hubs.ly/Q04rDLWZ0[5] We opened our site for an afternoon of networking, a panel with Resilience President & CEO William S. Marth[6], Edgardo Hernandez[7], Executive Vice President and President of Manufacturing Operations at Eli Lilly and Company, Josh Matson[8], VP, Gene...